Dr. Concetta M. Forchetti, M.D.
Neurology (Neurology Physician)
800 Biesterfield Rd Ste 610
Elk Grove Village, IL 60007
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 50
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 317
Licensed in Illinois since 1988, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
IL license 036076911 (first issued 1988; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwest Community Hospital 1 Arlington Heights, IL
- Advocate Sherman Hospital Elgin, IL
- Alexian Brothers Medical Center 1 Elk Grove Village, IL
- St Alexius Medical Center Hoffman Estates, IL
Medical groups
- Bonaventure Medical Foundation LLC (167 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 317
- Services billed
- 534
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 240 | 197 |
| New patient office or other outpatient visit, 60-74 minutes | 151 | 151 |
| Established patient office or other outpatient visit, 40-54 minutes | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 49 payments worth $50,288 in total to this clinician.
| Lilly USA, LLC | $50,117 |
|---|---|
| Otsuka America Pharmaceutical, Inc. | $119 |
| Celgene Corporation | $31.47 |
| Boston Scientific Corporation | $20.43 |
| Compensation for services other than consulting (speaking, faculty) | $47,000 |
|---|---|
| Travel and Lodging | $2,475 |
| Food and Beverage | $812 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Lilly USA, LLC Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $6,250 |
| Lilly USA, LLC May 22, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
All 39 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Lilly USA, LLC Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
| Lilly USA, LLC Nov 13, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to MELROSE PARK, IL | $25.90 |
| Lilly USA, LLC Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,575 |
| Lilly USA, LLC Nov 6, 2025 | Travel and Lodging travel to MOKENA, IL · in-kind | $642 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to LOMBARD, IL | $33.11 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to LOMBARD, IL | $2.70 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
| Lilly USA, LLC Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
| Lilly USA, LLC Oct 29, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to ARLINGTON HEIGHTS, IL | $11.76 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,575 |
| Lilly USA, LLC Oct 21, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $20.79 |
| Lilly USA, LLC Oct 21, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $20.00 |
| Lilly USA, LLC Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
| Lilly USA, LLC Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $6,250 |
| Lilly USA, LLC Jul 8, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to GLENVIEW, IL | $32.34 |
| Lilly USA, LLC Jul 8, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to GLENVIEW, IL | $3.80 |
| Lilly USA, LLC May 22, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC May 22, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
| Lilly USA, LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,250 |
| Lilly USA, LLC May 13, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,250 |
| Lilly USA, LLC Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,575 |
| Lilly USA, LLC Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,575 |
| Lilly USA, LLC Apr 15, 2025 | Travel and Lodging travel to DYER, IN · in-kind | $687 |
| Lilly USA, LLC Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $1,250 |
| Lilly USA, LLC Apr 8, 2025 | Travel and Lodging travel to MADISON, WI · in-kind | $916 |
| Lilly USA, LLC Mar 26, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $39.52 |
| Lilly USA, LLC Mar 26, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $33.00 |
| Lilly USA, LLC Mar 26, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $5.00 |
| Lilly USA, LLC Mar 26, 2025 | Travel and Lodging KISUNLA · Neuroscience · travel to CHICAGO, IL | $2.35 |
| Lilly USA, LLC Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $2,500 |
| Lilly USA, LLC Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) KISUNLA · Neuroscience | $950 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 15 industry-funded studies in 2025, from 6 companies. The companies reported $908,465 in research payments for these studies, mostly to the institutions running them.
- A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Eli Lilly and Company · Completed · NCT06538116 - A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Eli Lilly and Company · Active, not recruiting · NCT06653153 - A Randomized Double blind Placebo controlled Parallel group Multi Center Study to Assess the Efficacy and Safety of JNJ63733657 an Antitau Monoclonal Antibody in Participants with Early Alzheimer's Disease
Janssen Research & Development, LLC - A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (Targe…
E.r. Squibb & Sons, L.l.c. - A phase 2, parallel group, randomized, double-blind, placebo-controlle
GlaxoSmithKline, LLC. - A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease
Biogen, Inc. - A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild-to-Moderate Alzheimer…
E.r. Squibb & Sons, L.l.c. - Assessment of safety and efficacy of subcutaneous remternetug in early symptomatic alzheimer's disease
Eli Lilly and Company - A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Eli Lilly and Company · Active, not recruiting · NCT05026866 - A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
E.r. Squibb & Sons, L.l.c. · Active, not recruiting · NCT06025578
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.